S100P and chronic hepatitis: Our results revealed that there were significantly higher percentages of HBsAg positive status, chronic hepatitis, and liver cirrhosis in S100P-SPP1 + iCCApps than in S100P + SPP1− iCCAphl, further highlighting their distinct pathogenic background.